In Vitro Experimental Study of Drug-loaded Nanoparticles with Phase-changed Capability for Multimodal Imaging and Sonodynamic Therapy combined with Chemotherapy
In Vitro Experimental Study of Drug-loaded Nanoparticles with Phase-changed Capability for Multimodal Imaging and Sonodynamic Therapy combined with Chemotherapy[J]. Journal of Clinical Ultrasound in Medicine, 2021,23(10).
In Vitro Experimental Study of Drug-loaded Nanoparticles with Phase-changed Capability for Multimodal Imaging and Sonodynamic Therapy combined with Chemotherapy[J]. Journal of Clinical Ultrasound in Medicine, 2021,23(10).DOI:
Objective To prepare poly (lactic-co-glycolic acid) (PLGA) based multifunctional nanoparticles loading with perfluoropentane (PFP)
Mn (5
10
15
20-tetrakis (4-chlorophenyl) porphyrin) Cl (MnTTP) and paclitaxel (PTX)
and to investigate their ultrasound (US)/photoacoustic (PA)/magnetic resonance (MR) imaging enhancement capability and chemo-/sonodynamic therapy (SDT) efficacy in vitro. Methods PFP/MnTTP/PTX loaded in PLGA nanoparticles (termed as FMP@P) were prepared by a double emulsification method. The physical properties of FMP@P including average diameter
surface zeta potential
morphological character
drug loading efficacy and in vitro reactive oxygen species (ROS) generation were determined. In addition
the in vitro PA/US/MR imaging performance of FMP@P was observed and recorded. Upon US irradiation
intercellular ROS generation was investigated using confocal microscopy and flowcytometry. Meanwhile
the chemo-/sonodynamic therapy effect on 4T1 cell was evaluated by the standard CCK-8 assay and flow cytometry. Results The average diameter and zeta potential of FMP@P were (323.1 ± 68.3) nm and -(14.5 ± 8.3) mV. The loading efficiency of MnTTP and PTX was 93.55 ± 0.46% and 81.23 ± 6.93%
respectively. FMP@P enhanced US/PA/MR imaging. Upon US irradiation
FMP@P could produce a large amount of reactive oxygen species (ROS)
which induced obvious cytotoxicity. Conclusion A multifunctional FMP@P were successfully fabricated